by Merck & Co. To Acquire Verona Pharma for $10 Bn
Merck has agreed to acquire biopharmaceutical company Verona Pharma in a deal valued at $10bn. The acquisition will be made by the subsidiary of Merck, which is known as MSD outside of the US and...
Torrent Pharmaceuticals to acquire stake in JB Pharma for $3bn
Torrent Pharmaceuticals, has signed definitive agreements for the acquisition of a controlling stake in JB Chemicals and Pharmaceuticals (JB Pharma) from global investment firm KKR at an equity...
Sun Pharma Completes its Acquisition of Checkpoint Therapeutics
Sun Pharmaceutical Industries Limited had announced the successful completion of its acquisition of Checkpoint Therapeutics, Inc. an immunotherapy and targeted oncology company. As part of the...
Kite to Acquire Interius BioTherapeutics
Kite, a Gilead Company , announced that it has entered into a definitive agreement to acquire Interius BioTherapeutics, a privately held biotechnology company developing in vivo CAR...
AbbVie to acquire Gilgamesh Pharma mental disorder candidate for $1.2 Bn
AbbVie has signed a definitive agreement to acquire Gilgamesh Pharmaceuticals’ lead investigational candidate, bretisilocin, for up to $1.2bn, including an upfront payment and development milestones....
Merck KGaA’s acquisition of SpringWorks Therapeutics
Merck, a leading science and technology company, had announced that it has closed the acquisition of SpringWorks Therapeutics, for an enterprise value of $3.4 billion, following regulatory clearances...
Roche signs agreement to acquire 89bio in $2.4bn deal
Roche has signed a definitive merger agreement for the acquisition of clinical-stage biopharmaceutical company 89bio, for a total equity value of around $2.4bn. Under the deal, Roche will initiate a...